drugset / Trial / NCT00297180

Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks

NCT00297180

Phase 2 Completed 136 enrolled GlaxoSmithKline
RandomizedSingle-groupDouble-blindTreatment

Summary

GW869682 causes glucose to be excreted in the urine. The purpose of this study is to see whether enough calories from glucose are excreted in the urine to cause weight loss.

Timeline

Start
2006-01
Primary completion
2006-09
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject GW869682 Unknown

Indications